Simulations Plus, Inc. (NASDAQ:SLP) Q2 2024 Earnings Call Transcript
Simulations Plus, Inc. beats earnings expectations. Reported EPS is $0.1983, expectations were $0.18. Simulations Plus, Inc.
Stay updated with breaking news from Simulations Plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Simulations Plus, Inc. beats earnings expectations. Reported EPS is $0.1983, expectations were $0.18. Simulations Plus, Inc.
-- Technology stocks were rising premarket Thursday, with the Technology Select Sector SPDR Fund gaining 0.4% while the SPDR S&P Semiconductor ETF was flat. Simulations Plus surged past 10% after...
-- Simulations Plus said Thursday that the US Food and Drug Administration has renewed its licenses to the DILIsym software platform. Financial details weren't disclosed. The one-year renewal will...
Simulations Plus, Inc. announced that the U.S. FDA has renewed its licenses to the DILIsym software platform. DILIsym is the industry gold standard for quantitative systems toxicology software...
Shares of Simulations Plus, Inc. (NASDAQ:SLP – Get Free Report) gapped up before the market opened on Thursday following a better than expected earnings announcement. The stock had previously closed at $38.46, but opened at $44.91. Simulations Plus shares last traded at $46.28, with a volume of 95,888 shares changing hands. The technology company reported […]